MyFinsight
Home
Blog
About
Contact
Proceeds from issuance of
convertible notes payable
$392K
Proceeds from issuance of
note payable, net
$288K
Proceeds from sale of
fixed assets
$12K
Proceeds from issuance of
common shares, net
$41K
Net cash provided by
financing activities -...
$677K
Net cash provided by
investing activities -...
$12K
Canceled cashflow
$44K
Net cash provided by
financing activities
$677K
Net cash provided by
investing activities
$12K
Repayment of note payable
$44K
Decrease in cash and cash
equivalents
-$59K
Canceled cashflow
$689K
Net cash used in
operating activities
-$748K
Accounts payable and
accrued expenses
$1,180K
Depreciation and
amortization
$962K
Income tax payable
$512K
Deferred revenue
$484K
Amortization of debt discount
$476K
Stock-based compensation
expense
$390K
Debt extinguishment
loss
-$278K
Loss from investment
in unconsolidated...
-$225K
Change in fair value of
derivative liability
-$86K
Other liabilities
$79K
Lease liabilities
$39K
Loss on issuance of
debt
-$12K
Net cash used in
operating activities -...
-$748K
Canceled cashflow
$4,723K
Loss from continuing
operations after income...
-$5,354K
Prepaid expenses and
other current assets
$104K
Accounts receivable
$7K
Loss (gain) from
disposal of fixed assets
$6K
Back
Back
Cash Flow
ProPhase Labs, Inc. (PRPH)
ProPhase Labs, Inc. (PRPH)
source: myfinsight.com